Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -0.37% | 333.61 | 0.0% | $4529.69m | |
| NVAX | Novavax, Inc. | -3.43% | 160.55 | 79.4% | $722.22m | |
| BNTX | BioNTech SE | 0.67% | 262.85 | 0.0% | $709.55m | |
| AMGN | Amgen, Inc. | 1.80% | 206.78 | 1.4% | $547.92m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -1.92% | 6.14 | 0.7% | $429.21m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.59% | 552.11 | 2.7% | $426.22m | |
| GILD | Gilead Sciences, Inc. | 1.52% | 66.90 | 1.0% | $414.02m | |
| CCXI | ChemoCentryx, Inc. | 3.76% | 33.65 | 2.9% | $399.69m | |
| ILMN | Illumina, Inc. | 0.87% | 414.08 | 3.3% | $377.90m | |
| XLRN | Acceleron Pharma, Inc. | 0.43% | 173.74 | 5.3% | $364.00m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 2.55% | 185.41 | 1.9% | $264.85m | |
| BIIB | Biogen, Inc. | -0.59% | 268.13 | 1.7% | $232.27m | |
| OCGN | Ocugen, Inc. | 0.85% | 8.33 | 0.0% | $180.05m | |
| XENE | Xenon Pharmaceuticals, Inc. | -2.96% | 29.81 | 0.4% | $166.66m | |
| DNA | Ginkgo Bioworks Holdings, Inc. | 20.21% | 14.81 | 0.0% | $162.54m |
Company Profile
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.